HPV Vaccine (Gardasil)
Indication:

• 9 to 26 years old girls/women preferably before onset of sexual activity

 

Nature of the vaccine

•  Prophylactic vaccine developed to prevent about 70% of cervical cancer by preventing infection by two high risk HPV types 16 and 18

•  Main ingredients are highly purified inactive proteins from Human Papillomavirus Types 6, 11, 16 and 18; inactive ingredients include aluminum, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water for injection

 

Effectiveness of the vaccine:

•  Most effective in women who have never been exposed to HPV types 16 and 18 infections

•  Near 100% effective in preventing precancerous changes (CIN) caused by HPV types 16 and 18

•  Protects against 90% of HPV 6 and 11 related genital warts

•  Cannot prevent infection by HPV types other than HPV 6, 11, 16, 18

•  The remaining 30% to 50% of precancerous lesions (high grade CIN) are caused by other HPV types which are not protected by the vaccine

•  There is no therapeutic effect on existing abnormal cervical smear tests, HPV infection or genital warts. Therefore vaccination of these females is currently not recommended based on uncertain benefit

 

Side effects of the vaccine

•  Soreness, swelling, bleeding, redness or itching at the injection site

•  Fever and headache

•  Very rarely, bronchospasm

•  Allergy

 

Contraindications and precautions

•  Persons with a history of immediate hypersensitivity to yeast or any component of HPV vaccine

•  Pregnancy

•  Persons with thrombocytopenia or any coagulation disorder

•  Any illness with a fever higher than 100 0 F/37.8 0 C

•  Weakened immune system, for example due to a genetic defect or Human Immunodeficiency Virus (HIV) infection

 

Any special follow up

•  Should complete 3 doses of injection at 0, 2 and 6 months to get full protection

•  Should practise reliable contraception before completion of 3 doses

•  Should continue to have regular smear tests from cervical smear screening programme to detect any abnormal changes caused by other high risk HPV types

•  Current data showed that the vaccine should be protective for at least 5 years, the need for a booster injection is not yet known

•  Other ways to prevent cervical cancer include leading a healthy life style (such as having a balanced diet and avoiding smoking) and practicing safe sex (such as using condom and having a single sexual partner).

 

Questions and Answers for Human Papilloma Virus (HPV) Vaccine

Charges

Cervical screening programme, Department of Health, HKSAR